Showing results (1021-1030 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|February 28, 2012
Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signalingAlfeu Zanotto-Filho, Elizandra Braganhol, Ana Maria Oliveira Battastini, et al.
Investigational New Drugs|August 23, 2008
Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cellsG Harish Kumar, K V P Chandra Mohan, A Jagannadha Rao, et al.
Investigational New Drugs|September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumorsCatherine Delbaldo, Eric Raymond, Karina Vera, et al.
Investigational New Drugs|July 31, 2008
Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesisGopalakrishnan Ramakrishnan, Sundaram Jagan, Sattu Kamaraj, et al.
Investigational New Drugs|January 1, 1986
Oral idarubicin in non-Hodgkin's lymphomasM Lopez, L Di Lauro, P Papaldo
Investigational New Drugs|January 1, 1986
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trialH S Hochster, M D Green, R H Blum, et al.
Investigational New Drugs|July 3, 2019
In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101Laura Masuelli, Monica Benvenuto, Valerio Izzi, et al.
Investigational New Drugs|January 1, 1986
Heterogeneous survival responses of human gastric cancer clones to alpha difluoromethylornithine in vitroS C Barranco, P J Ford, C M Townsend
Investigational New Drugs|January 1, 1986
Cell cycle kinetics responses of human stomach cancer cells to reduction in polyamine levels by treatment with alpha difluoromethylornithine in vitroS C Barranco, P J Ford, C M Townsend
Investigational New Drugs|May 19, 2019
Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathwayGaochao Hou, Xiang Yuan, Yi Li, et al.
Pageof 372